Home » Newsletters » BioWorld Science

BioWorld Science

June 15, 2006

View Archived Issues

Snapshots of endocrine therapy presentations from ASCO

PharmAthene and SIGA Technologies to merge

PTC Therapeutics and CV Therapeutics establish research collaboration

SPI-1005 begins clinical testing for noise induced hearing loss

Cephalon and Takeda to copromote Provigil

CP-751871 assessed in phase I cancer trials

TAS-102 regimens assessed in phase I cancer studies

Galapagos to acquire DPI's drug discovery service operations

Novartis and Intercell sign Japanese encephalitis vaccine agreement

Somatostatin sst4 receptor agonists as new prospects for pain therapy / News in Context

Talotrexin evaluated in phase I trials in solid tumors and non-small cell lung cancer

Study determines phase II regimen of SB-743921 in patients with solid tumors

Clinical trial results for gimatecan presented at ASCO meeting

Snapshots of clinical trials of heat shock protein 90 inhibitors presented at ASCO 2006

CPT-L2-BA3 targets bombesin receptors to induce cytotoxicity in several human cancers

Almirall and Meda form strategic partnership over inhalation products division

Phase II data for antithrombosis drug BAY-59-7939 support entry to phase III

Maturation inhibitor bevirimat begins phase IIb study

Preclinical findings for Lipoxen's vaccine delivery technology ImuXen

Clavis cleared for phase I study of CP-4126 in solid tumors

New asthma compound enters phase IIb from Beyond Advair collaboration

MediciNova begins development of MN-221 for status asthmaticus

Ceflatonin studied in CML patients with T315I mutation

MyVax personalized immunotherapy receives fast track status for follicular NHL

SPA for phase II/III study of Bexidem in superficial bladder cancer

Fast track designation for Nexavar in metastatic hepatocellular carcinoma

New orphan drug designations for rhC1INH

Recent patents cover novel therapeutic agents for neurological disorders

Vivitrol for alcohol dependence now available

Novel treatment options for metabolic disorders described in recent patents

Antigenics presents preclinical data on its novel genital herpes vaccine

Novel insulin sensitizing syncretic drug developed at CombinatoRx shows antidiabetic activity in rat

FG-3019 prevents diabetes-induced cardiovascular complications in diabetic rats

Preclinical findings on metaglidasen presented by Metabolex

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...